American CryoStem Corporation entered into a licensing agreement with Cell Source (CS). Under terms of the agreement, American CryoStem has licensed to CS the rights to utilize its Standard Operating Procedures (SOP's) to create and market its ATGRAFT(TM) tissue storage service in Japan.
American CryoStem Corporation
Equities
CRYO
US0253001046
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 42.75B | |
+47.70% | 41.61B | |
+11.98% | 41.34B | |
-8.83% | 26.59B | |
+7.73% | 25.49B | |
-22.70% | 18.12B | |
+30.71% | 12.24B | |
-1.73% | 11.76B | |
+9.40% | 11B |
- Stock Market
- Equities
- CRYO Stock
- News American CryoStem Corporation
- American Cryostem Corporation Signs Licensing Agreement with Cell Source